A citation-based method for searching scientific literature

Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
Times Cited: 258



Naoki Oishi, Tetsuo Kondo, Aya Ebina, Yukiko Sato, Junko Akaishi, Rumi Hino, Noriko Yamamoto, Kunio Mochizuki, Tadao Nakazawa, Hiroshi Yokomichi, Koichi Ito, Yuichi Ishikawa, Ryohei Katoh. Mod Pathol 2017
Times Cited: 38




List of shared articles



Times cited

Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential: Advantages of the Digital Droplet PCR Technique.
Martin Hysek, Kenbugul Jatta, L Samuel Hellgren, Adam Stenman, Catharina Larsson, Jan Zedenius, C Christofer Juhlin. J Mol Diagn 2021
4

Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
Jinwei Hu, Isabella J Yuan, Saied Mirshahidi, Alfred Simental, Steve C Lee, Xiangpeng Yuan. Int J Mol Sci 2021
2


Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma.
Tatsuya Hirokawa, Yuu Arimasu, Tomohiro Chiba, Masachika Fujiwara, Hiroshi Kamma. Pathol Int 2020
0

Molecular therapeutics for anaplastic thyroid cancer.
Nikita Pozdeyev, Madison M Rose, Daniel W Bowles, Rebecca E Schweppe. Semin Cancer Biol 2020
10


Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations.
Naoki Oishi, Huy Gia Vuong, Kunio Mochizuki, Tetsuo Kondo. Endocr Pathol 2020
2


Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.
Junko Akaishi, Tetsuo Kondo, Kiminori Sugino, Yuna Ogimi, Chie Masaki, Kiyomi Y Hames, Tomonori Yabuta, Chisato Tomoda, Akifumi Suzuki, Kenichi Matsuzu,[...]. World J Surg 2019
6

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, Tomoe Nakao, Kosho Yamanouchi, Chika Sakimura, Hiroshi Yano, Eijun Nishihara, Mitsuyoshi Hirokawa, Keiji Suzuki,[...]. Thyroid 2019
17

Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor.
Sevim Dalva-Aydemir, Cemaliye Boylu Akyerli, Şirin Kılıçturgay Yüksel, Hilal Keskin, Mustafa Cengiz Yakıcıer. OMICS 2019
3